Fortrea Holdings FTRE
NASDAQ FTRE
$18.24 -0.38 (-2.04%)
As of: Sep 4, 2026 · 12:49 PM EDT

Fortrea Holdings (FTRE) Depreciation & Amortization (CF) (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Depreciation & Amortization (CF) came in at $19.6 million in Q2 2026, little changed YoY from $19.6 million in Q2 2025, and down 1.01% on a QoQ basis from $19.8 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has 5 years of Depreciation & Amortization (CF) data on file, last reported at $19.6 million in Q2 2026.

  • Quarterly Depreciation & Amortization (CF) changed 0.0% year-over-year to $19.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $78.3 million (down 3.45% YoY) and the FY2025 annual result came in at $78.0 million, down 10.24% from the prior year.
  • Depreciation & Amortization (CF) eased to $19.6 million in Q2 2026, from $19.8 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $25.1 million in Q2 2023 to a low of $19.3 million in Q4 2025.
  • A 5-year average of $21.9 million and a median of $21.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) grew 8.37% — and 2025, when it declined 17.02%.
  • Tracing FTRE's Depreciation & Amortization (CF) over 5 years: stood at $23.9 million in 2022, then increased by 2.09% to $24.4 million in 2023, then slipped by 14.75% to $20.8 million in 2024, then slipped by 7.21% to $19.3 million in 2025, then rose by 1.55% to $19.6 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $19.6 million (Q2 2026), $19.8 million (Q1 2026), and $19.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn -
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - -
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.52 Bn 27.68 Bn - -
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -
10 Fortrea Holdings 1.73 Bn 1.56 Bn 139.20 Mn 19.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.60 Mn
Mar 31, 2026 19.80 Mn
Dec 31, 2025 19.30 Mn
Sep 30, 2025 19.60 Mn
Jun 30, 2025 19.60 Mn
Mar 31, 2025 19.50 Mn
Dec 31, 2024 20.80 Mn
Sep 30, 2024 21.20 Mn
Jun 30, 2024 21.40 Mn
Mar 31, 2024 23.50 Mn
Dec 31, 2023 24.40 Mn
Sep 30, 2023 24.60 Mn
Jun 30, 2023 25.10 Mn
Mar 31, 2023 23.10 Mn
Dec 31, 2022 23.90 Mn
Sep 30, 2022 22.70 Mn
Jun 30, 2022 23.40 Mn